TBPN cover image

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN

00:00

Why Start with Dogs for Longevity Drugs?

Celine explains faster timelines, translational value, and regulatory incentives that make canine trials attractive for longevity research.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app